Sei Investments CO Monte Rosa Therapeutics, Inc. Transaction History
Sei Investments CO
- $75.3 Billion
- Q4 2024
A detailed history of Sei Investments CO transactions in Monte Rosa Therapeutics, Inc. stock. As of the latest transaction made, Sei Investments CO holds 17,236 shares of GLUE stock, worth $108,759. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,236Holding current value
$108,759% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding GLUE
# of Institutions
93Shares Held
50.4MCall Options Held
141KPut Options Held
31.2K-
Nea Management Company, LLC Timonium, MD7.69MShares$48.5 Million3.11% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.6MShares$41.7 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY5.79MShares$36.5 Million0.46% of portfolio
-
Versant Venture Management, LLC San Francisco, CA5.65MShares$35.7 Million58.01% of portfolio
-
Baker Bros. Advisors LP New York, NY4.92MShares$31 Million0.28% of portfolio
About Monte Rosa Therapeutics, Inc.
- Ticker GLUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,713,900
- Market Cap $295M
- Description
- Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral molecular glue degrader for GSPT1, a translational termination factor and degron-containing prot...